Aerie Pharmaceuticals raises $125 million in ATM sales and upsized follow-on offering
Aerie Pharma announced it has priced its registered underwritten public offering of $75 million of shares of its common stock at a price to the public of $53.75 per share. The offering was upsized by $25 million. Total gross proceeds are expected to be $125 million. May 26, 2017